Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome

American Journal of Medical Genetics, Part A

Volumn 143, Issue 15, 2007, Pages 1767-1770

  Jackson, Eric M ^a   Shaikh, Tamim H ^a,b   Zhang, Fan ^b   Wainwright, Luanne M ^b   Storm, Phillip B ^a,b   Hakonarson, Hakon ^b   Zackai, Elaine H ^a,b   Biegel, Jaclyn A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Beckwith Wiedemann syndrome; INI1 hSNF5 SMARCB1 BAF47; Rhabdoid tumor

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER SUSCEPTIBILITY; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 22; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INI1 GENE; MALE; MONOSOMY; PRIORITY JOURNAL; RHABDOID TUMOR; SOMATIC MUTATION; TERATOMA; TUMOR DIAGNOSIS; TUMOR GENE;

BECKWITH-WIEDEMANN SYNDROME; BRAIN; HUMANS; INFANT; MALE; RHABDOID TUMOR; TERATOMA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34547665402     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31843     Document Type: Article

References (29)

1. Ae K, Kobayashi N, Sakuma R, Ogata T, Kuroda H, Kawaguchi N, Shinomiya K, Kitamura Y. 2002. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells. Oncogene 21:3112-3120.
2. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. 2002. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 21:5193-5203.
3. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. 1999. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79.
4. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. 2002. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461-3467.
5. Bliek J, Maas SM, Ruijter JM, Hennekam RC, Alders M, Westerveld A, Mannens MM. 2001. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQIOT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 10:467-476.
6. Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J, Schofield PN, Reik W, Macdonald F, Maher ER. 2005. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025-1032.
7. DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP. 2002. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70:604-611.
8. El Kababri M, Andre N, Carole C, Lena G, Figarella-Branger D, Gentet JC. 2006. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis 1. Pediatr Blood Cancer 46:267-268.
9. Engel JR, Smallwood A, Harper A, Higgins MJ, Oshimura M, Reik W, Schofield PN, Maher ER. 2000. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 37:921-926.
10. Gaston V, Le Bouc Y, Soupre V, Burglen L, Donadieu J, Oro H, Audry G, Vazquez MP, Gicquel C. 2001. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet 9:409-418.
11. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano AN, Jones SN. 2001. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 21:3598-3603.
12. Karnes PS, Tran TN, Cui MY, Bogenmann E, Shimada H, Ying KL. 1991- Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23). Cancer Genet Cytogenet 56:31-38.
13. Medjkane S, Novikov E, Versteege I, Delattre O. 2004. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res 64:3406-3413.
14. Muchardt C, Yaniv M. 1999. The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 10:189-195.
15. Muchardt C, Yaniv M. 2001. When the SWI/SNF complex remodels. . .the cell cycle. Oncogene 20:3067-3075.
16. Nagata T, Takahashi Y, Ishii Y, Asai S, Sugahara-Kobayashi M, Nishida Y, Murata A, Yamamori S, Ogawa Y, Nakamura T, Murakami H, Nakamura M, Shichino H, Chin M, Sugito K, Ikeda T, Koshinaga T, Mugishima H. 2005. Molecular genetic alterations and gene expression profile of a malignant rhabdoid tumor of the kidney. Cancer Genet Cvtogenet 163:130-137.
17. Peiffer DA, Le JM, Steemers FJ, Chang W, Jenniges T, Garcia F, Haden K, Li J, Shaw CA, Belmont J, Cheung SW, Shen RM, Barker DL, Gunderson KL. 2006. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16:1136-1148.
18. Reincke BS, Rosson GB, Oswald BW, Wright CF. 2003. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells. J Cell Physiol 194:303-313.
19. Rorke LB, Packer RJ, Biegel JA. 1996. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J Neurosurg 85:56-65.
20. Rump P, Zeegers MP, van Essen AJ. 2005. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am J Med Genet Part A 136A:95-104.
21. Sait SN, Nowak NJ, Singh-Kahlon P, Weksberg R, Squire J, Shows TB, Higgins MJ. 1994. Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chromosomes Cancer 11:97-105.
22. Schofield DE, Beckwith JB, Sklar J. 1996. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer 15:10-17.
23. Thorburn MJ, Wright ES, Miller CG, Smith-Read EH. 1970. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child 119:316-321.
24. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206.
25. Versteege I, Medjkane S, Rouillard D, Delattre O. 2002. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 21:6403-6412.
26. Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, Verrijzer CP. 2005. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19:665-670.
27. Weksberg R, Nishikawa J, Caluseriu O, Fei YL, Shuman C, Wei C, Steele L, Cameron J, Smith A, Ambus I, Li M, Ray PN, Sadowski P, Squire J. 2001. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1 OT1. Hum Mol Genet 10:2989-3000.
28. Weksberg R, Smith AC, Squire J, Sadowski P. 2003. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12 Spec No 1:R61-R68.
29. Weksberg R, Shuman C, Smith AC. 2005. Beckwith-Wiedemann syndrome. Am J Med Genet Part C 137C:12-23.